Miguel Garcia-Guzman

Qureator, a biomedical company, focuses on the development of novel platforms and high-throughput disease models for precision medicine in areas of high unmet medical needs. The company provides Microphysiological Systems (MPS) which enable investigators to perform co-cultures of multiple cell types in 3D and high-throughput screenings for biomedical research and drug discovery.